Table 1.
Patient characteristics clinicopathological variables and their prognostic variables for BF, CF and PCD (univariate analysis; log-rank test) (N = 535).
Fig 1.
Representative immunohistochemical staining for Ki-67.
(A) Gleason grade group 1 (3+3) with Ki-67 <1–2.5%; (B) Gleason grade group 3 (4+3) with Ki-67 <1–2.5%; (C) Gleason grade group 3 (4+3) with Ki-67 2.6–4%; (D) Gleason grade group 4 (4+4) with Ki-67 ≥ 5; (E) Gleason grade group 5 (4–5) with Ki-67 2.6–4; (F) Picture showing the different Ki-67 expression of nuclear staining, varying from negative to strong.
Fig 2.
Survival analysis for Ki-67 and mitotic count in primary tumors.
(Kaplan-Meier method). Number of events/number of cases are given in parenthesis. (A) Digital scoring; (B) Visual scoring.
Table 2.
Multivariate analyses (Cox regression, backward conditional) of Ki67 levels and significant clinicopathological variables.
(n = 535). Digital scoring method.
Table 3.
Multivariate analyses (Cox regression, backward conditional) of Ki67 levels and significant clinicopathological variables.
(n = 535). Visual scoring method.